Waratah Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,721
Closed -$1.82M 177
2023
Q1
$1.82M Buy
+11,721
New +$1.89M 0.04% 124
2014
Q4
Sell
-28,725
Closed -$3.06M 85
2014
Q3
$3.06M Sell
28,725
-5,700
-17% -$591K 2.19% 13
2014
Q2
$3.6M Sell
34,425
-4,475
-12% -$452K 1.76% 17
2014
Q1
$3.82M Buy
38,900
+25,700
+195% +$2.38M 2.1% 15
2013
Q4
$1.21M Buy
+13,200
New +$1.22M 0.46% 52

Other funds holding JNJ

Waratah Capital Advisors's JNJ Position: Q2 2023 in Review

Waratah Capital Advisors sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 11,721 shares — an estimated $1.82M sold.

Waratah Capital Advisors first reported a position in JNJ in Q4 2013 and held it in 5 quarters. The position peaked at $3.82M in Q1 2014. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • Waratah Capital Advisors reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • Waratah Capital Advisors sold 11,721 Johnson & Johnson shares in Q2 2023, an estimated $1.82M.
  • Waratah Capital Advisors first reported a position in Johnson & Johnson in Q4 2013 and held it in 5 quarters.
  • Waratah Capital Advisors's Johnson & Johnson position peaked at $3.82M in Q1 2014.
  • 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Waratah Capital Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.